These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 7288634)

  • 21. A conjugated diene identified as a prohapten: contact allergenic activity and chemical reactivity of proposed epoxide metabolites.
    Nilsson AM; Bergström MA; Luthman K; Nilsson JL; Karlberg AT
    Chem Res Toxicol; 2005 Feb; 18(2):308-16. PubMed ID: 15720137
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro metabolism of 4-vinylcyclohexene in rat and mouse liver, lung, and ovary.
    Keller DA; Carpenter SC; Cagen SZ; Reitman FA
    Toxicol Appl Pharmacol; 1997 May; 144(1):36-44. PubMed ID: 9169067
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epoxidation of androsta-5,16-dien-3 beta-ol by hepatic microsomal lipid peroxidation.
    Watabe T; Kobayashi K; Saitoh Y; Komatsu T; Ozawa N; Tsubaki A; Endoh K; Hiratsuka A
    J Biol Chem; 1986 Mar; 261(7):3200-7. PubMed ID: 3949767
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Formation of irreversible protein-binding metabolites during microsomal metabolism of 14C-bromobenzene and 14C-bromophenol.
    Hesse S; Wolff T; Mezger M
    Adv Exp Med Biol; 1981; 136 Pt A():387-93. PubMed ID: 7344470
    [No Abstract]   [Full Text] [Related]  

  • 25. Metabolism of the cytochrome P450 mechanism-based inhibitor N-benzyl-1-aminobenzotriazole to products that covalently bind with protein in guinea pig liver and lung microsomes: comparative study with 1-aminobenzotriazole.
    Woodcroft KJ; Webb CD; Yao M; Weedon AC; Bend JR
    Chem Res Toxicol; 1997 May; 10(5):589-99. PubMed ID: 9168258
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro studies on the metabolic activation of the furanopyridine L-754,394, a highly potent and selective mechanism-based inhibitor of cytochrome P450 3A4.
    Sahali-Sahly Y; Balani SK; Lin JH; Baillie TA
    Chem Res Toxicol; 1996 Sep; 9(6):1007-12. PubMed ID: 8870989
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bioactivation of coumarin in rat olfactory mucosal microsomes: Detection of protein covalent binding and identification of reactive intermediates through analysis of glutathione adducts.
    Zhuo X; Zhao W; Zheng J; Humphreys WG; Shu YZ; Zhu M
    Chem Biol Interact; 2009 Oct; 181(2):227-35. PubMed ID: 19576871
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of adducts of bromobenzene 3,4-oxide with rat liver microsomal protein sulfhydryl groups using specific antibodies.
    Rombach EM; Hanzlik RP
    Chem Res Toxicol; 1999 Feb; 12(2):159-63. PubMed ID: 10027793
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro metabolism and covalent binding among ortho-substituted bromobenzenes of varying hepatotoxicity.
    Weller PE; Narasimhan N; Buben JA; Hanzlik RP
    Drug Metab Dispos; 1988; 16(2):232-7. PubMed ID: 2898339
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of three protein targets for reactive metabolites of bromobenzene in rat liver cytosol.
    Koen YM; Williams TD; Hanzlik RP
    Chem Res Toxicol; 2000 Dec; 13(12):1326-35. PubMed ID: 11123975
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Involvement of cytochrome P-450IIIA in metabolism of potassium canrenoate to an epoxide: mechanism of inhibition of the epoxide formation by spironolactone and its sulfur-containing metabolite.
    Cook CS; Hauswald C; Oppermann JA; Schoenhard GL
    J Pharmacol Exp Ther; 1993 Jul; 266(1):1-7. PubMed ID: 8331551
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of dithiocarb and dimethyl sulfoxide on irreversible binding of 14C-bromobenzene to rat liver microsomal protein.
    Younes M; Siegers CP; Filser JG
    Arch Toxicol; 1979 Sep; 42(4):289-93. PubMed ID: 229786
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Imipramine-induced inactivation of a cytochrome P450 2D enzyme in rat liver microsomes: in relation to covalent binding of its reactive intermediate.
    Masubuchi Y; Igarashi S; Suzuki T; Horie T; Narimatsu S
    J Pharmacol Exp Ther; 1996 Nov; 279(2):724-31. PubMed ID: 8930177
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Macromolecular weight specificity in covalent binding of bromobenzene.
    Sun JD; Dent JG
    Toxicol Appl Pharmacol; 1984 Nov; 76(2):243-51. PubMed ID: 6495332
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Conversion of bromobenzene to 3-bromophenol. A route to 3- and 4-bromophenol through sulfur-series intermediates derived from the 3,4-oxide.
    Lertratanangkoon K; Horning EC; Horning MG
    Drug Metab Dispos; 1987; 15(6):857-67. PubMed ID: 2893714
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bromobenzene and p-bromophenol toxicity and covalent binding in vivo.
    Monks TJ; Hinson JA; Gillette JR
    Life Sci; 1982 Mar; 30(10):841-8. PubMed ID: 7070199
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The rabbit liver microsomal biotransformation of 1,1-dialkylethylenes: enantioface selection of epoxidation and enantioselectivity of epoxide hydrolysis.
    Bellucci G; Chiappe C; Cordoni A; Marioni F
    Chirality; 1994; 6(3):207-12. PubMed ID: 8024951
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protein-reactive metabolites of carbamazepine in mouse liver microsomes.
    Lillibridge JH; Amore BM; Slattery JT; Kalhorn TF; Nelson SD; Finnell RH; Bennett GD
    Drug Metab Dispos; 1996 May; 24(5):509-14. PubMed ID: 8723729
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exploring the S4 and S1 prime subsite specificities in caspase-3 with aza-peptide epoxide inhibitors.
    Ganesan R; Jelakovic S; Campbell AJ; Li ZZ; Asgian JL; Powers JC; Grütter MG
    Biochemistry; 2006 Aug; 45(30):9059-67. PubMed ID: 16866351
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro immunosuppressive activity, isolation from pig liver microsomes and identification by electrospray ms-ms of a new FK-506 C19-C20 epoxide metabolite.
    Lhoëst G; Dieden R; Verbeeck RK; Maton N; Ingendoh A; Latinne D
    J Pharmacol Exp Ther; 1998 Mar; 284(3):1074-81. PubMed ID: 9495869
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.